Biallelic modification of  leads to severe combined immunodeficiency in pigs by unknown
RESEARCH Open Access
Biallelic modification of IL2RG leads to
severe combined immunodeficiency in pigs
Jung-Taek Kang1, Bumrae Cho1, Junghyun Ryu3, Caitlin Ray3, Eun-Jin Lee1, Yun-Jin Yun1, SunMi Ahn1, JinSeok Lee1,
Dal-Young Ji1, Nathaniel Jue4, Sherrie Clark-Deener4, Kiho Lee3* and Kwang-Wook Park1,2*
Abstracts
Background: Pigs with SCID can be a useful model in regenerative medicine, xenotransplantation, and cancer cell
transplantation studies. Utilizing genome editing technologies such as CRISPR/Cas9 system allows us to generate
genetically engineered pigs at a higher efficiency. In this study, we report generation and phenotypic characterization
of IL2RG knockout female pigs produced through combination of CRISPR/Cas9 system and SCNT. As expected, pigs
lacking IL2RG presented SCID phenotype.
Methods: First, specific CRISPR/Cas9 systems targeting IL2RG were introduced into developing pig embryos then the
embryos were transferred into surrogates. A total of six fetuses were obtained from the embryo transfer and fetal
fibroblast cell lines were established. Then IL2RG knockout female cells carrying biallelic genetic modification were used
as donor cells for SCNT, followed by embryo transfer.
Results: Three live cloned female piglets carrying biallelic mutations in IL2RG were produced. All cloned piglets completely
lacked thymus and they had a significantly reduced level of mature T, B and NK cells in their blood and spleen.
Conclusions: Here, we generated IL2RG knockout female pigs showing phenotypic characterization of SCID. This IL2RG
knockout female pigs will be a promising model for biomedical and translational research.
Keywords: IL2RG, Severe Combined Immunodeficiency (SCID), CRISPR/Cas9, Somatic cell nuclear transfer (SCNT),
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Background
The IL2RG gene, located on the X chromosome, encodes
the common gamma chain protein [35], which is a sub-
unit of various interleukin receptors that are involved in
immune system. The receptor is a key part of major
lymphocytes, therefore, supports the growth and matur-
ation of several subtypes of lymphocytes: T cells, B cells,
and natural killer (NK) cells. These lymphocytes are an
essential component of the adaptive and innate immune
system. Deletion or mutation in the IL2RG gene would
lead to the loss of functional immune system. Specifically,
IL2RG mutation results in X-linked severe combined im-
munodeficiency (XSCID), characterized by profound
defects in cellular and humoral immunity in humans
[2, 17, 24]. Transgenic mice lacking functional IL2RG
exhibits SCID phenotypes due to limited number of
mature B and T cells and the loss of NK cells [3].
These mice have been a useful resource for immuno-
logical, inflammation, oncology, and stem cell trans-
plantation studies [9, 32, 36]. However, rodent models
do not always recapitulate the genetic and physio-
logical states of humans. In fact, there are significant
differences in immune system between mice and
humans [22]. For example, expression and ligand
specificity of Toll-like receptors, which can activate
innate immune are different between human and
mouse [43]. Likewise, post-inflammatory genomic re-
sponses in mouse models poorly mimic human [31].
In addition, because of their size and shorter lifespan
compared to humans, mouse models are not ideal to
carry out surgical and clinical procedures or employ
long-term tracking and evaluation of tissue or cell
transplantation. Therefore, immunological assessments
and procedures developed using SCID mice as a
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model may not translate directly into the same out-
comes in humans.
Pigs are considered to be a leading large animal model
in biomedical research because they share similar anat-
omy and physiology with humans [26]. Various pig
models have been generated to study human diseases
such as cystic fibrosis [28], diabetes mellitus [27],
Alzheimer’s disease [13], and retinitis pigmentosa [29].
SCID pigs, in particular, can be a useful model in regen-
erative medicine, xenotransplantation, and cancer cell
transplantation researches because of similarities in
immune system between pigs and humans. Disruption
of IL2RG in male pigs resulted in immunodeficiency pre-
sented in X-linked SCID patients [34]; these pigs lacked
T and NK cells [34, 38]. Disruption of other key genes
related to immune response also resulted in the produc-
tion of SCID pigs lacking T and B cells [8, 14].
Conventionally significant effort is required to generate
these SCID pigs due to technical limitations. However,
recent advancement in genome editing technologies such
as CRISPR/Cas9 system allows us to generate genetically
engineered pigs at a higher efficiency and in a short period
of time, less than six months [14, 16]. The CRISPR/Cas9
system, originated from a natural microbial immune
system [1], consists of a RNA-guided Cas9 endonuclease,
a single guide RNA (sgRNA), and the trans-activating
CRISPR RNA (tracrRNA) which have been engineered for
genome editing in eukaryotic cells [4]. This CRISPR/Cas9
system has emerged as an efficient and powerful tool
for gene editing [11, 39], and been successfully ap-
plied in many mammals, including mice, rats, pigs,
and monkeys [6, 18, 19, 23, 37].
Here, we applied CRISPR/Cas9 technology to target
IL2RG during porcine embryogenesis, and generated
IL2RG knockout fibroblast cells from fetuses derived
from the embryos. Then the IL2RG knockout cells were
used as nuclear donors to produce IL2RG knockout
female pigs by somatic cell nuclear transfer (SCNT). As
a result, SCID pig models lacking mature lymphocytes
were generated, which could be a valuable large animal
model for human disease research or biomedical study.
Methods
Reagents
All chemicals in the study were purchased from Sigma–
Aldrich Chemical Company (St. Louis, MO, USA) unless
indicated otherwise.
Animals
All experiments involving animals were approved by the
Institutional Animal Care and Use Committee of the
institute of MGENPLUS co., Korea, and Virginia Tech
(#14-019). All the procedures were conducted under the
guidelines of the Committee. All surgical procedures
were performed under general anesthesia, and all neces-
sary efforts were made to minimize any potential suffer-
ing of animals. Pigs were maintained under conventional
housing conditions.
Design and construction of IL2RG targeting CRISPR/Cas9
system
The sgRNA that could recognize porcine IL2RG gene
were designed using an online CRISPR design tool (http://
zifit.partners.org/ZiFiT/Disclaimer.aspx). Sequence infor-
mation of the designed sgRNAs is 5′-CGAAGGTCCTCA
CGCACAGTGGG-3′ (gRNA #1) and 5′-CCGAAGGT
CCTCACGCACAGTGG-3′ (gRNA #2), respectively. The
PAM can be identified by the bold font in each sgRNA.
Specificity of the designed sgRNAs was confirmed by
searching for similar porcine sequences in GenBank. Both
sgRNAs are designed to create DSB in exon 1 of IL2RG.
The sgRNA sequences were introduced into the px330
vector (Addgene) as described previously (Additional file 1:
Table S1) [40]. Then the targeting vectors were used as a
template to generate sgRNA and Cas9 mRNA through in
vitro transcription (Additional file 1: Table S2).
Generation of IL2RG knockout fetuses by direct injection
of CRISPR/Cas9 system into early embryos
For in vitro maturation, cumulus oocyte complex (COC)
were maturated in vitro in a TCM-199 based maturation
media containing 0.5 IU/ml FSH, 0.5 IU/ml LH,
0.82 mM cysteine, 3.02 mM glucose, 0.91 mM sodium
pyruvate, and 10 ng/ml EGF. After 42–44 h of matur-
ation, cumulus cells were removed by incubating the
oocytes into a media containing 0.1 % hyaluronidase.
Oocytes that extruded the first polar body were used for
in vitro fertilization (IVF). Then mature oocytes, groups
of 25–30 oocytes, were placed in 50 μ l droplets of IVF
medium (modified Tris-buffered medium with 113.1 mM
NaCl, 3 mM KCl, 7.5 mM CaCl2, 11 mM glucose, 20 mM
Tris, 2 mM caffeine, 5 mM sodium pyruvate, and 2 mg/ml
BSA). Extended semen was washed with PBS three times
then the sperm pellet was resuspended with mTBM
media. Then, 50 μl sperm (2.5 × 105 sperm/ml) was intro-
duced into mTBM drops that contained oocytes. The
gametes were co-incubated for 5 h. Presumptive fertilized
embryos were then placed in Porcine Zygote Media 3
(PZM-3) [41] at 38.5 °C, 5 % CO2, and 5 % O2 incubator
until microinjection of CRISPR/Cas9 system. After 2–4 h
post-IVF, presumable zygotes were injected with RNA
form of CRISPR/Cas9 system to target IL2RG. Concentra-
tions of 10 ng/μl sgRNA and 20 ng/μl Cas9 mRNA was
injected into the cytoplasm of fertilized oocytes using a
FemtoJet microinjector (Eppendorf, Hamburg, Germany).
Microinjection was conducted in manipulation medium
(TCM199 with 0.6 mM NaHCO3, 2.9 mM HEPES,
30 mM NaCl, 10 ng/ml gentamicin, and 3 mg/ml BSA) on
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the heated stage of a Nikon inverted microscope (Nikon
Corporation, Tokyo, Japan). Injected zygotes were washed
then transferred and cultured into PZM-3. Embryos used
for embryo transfer were cultured in PZM-3 in the pres-
ence of 10 ng/ml GM-CSF [15] until embryo transfer. A
total of 245 microinjected embryos were transferred into
two surrogate sows at day 5 or 6 post-IVF. The embryos
were surgically transferred into the oviduct of the sows.
Establishing fibroblast cells from IL2RG knockout fetuses
For the collection of fetal fibroblast cells, porcine fetuses
were obtained on day 40 of gestation. Genomic DNAs
were isolated from each fetus using PureLink Genomic
DNA kit (Thermo Fisher Scientific, Waltham, MA,
USA) following the manufacturer’s instructions. PCR to
genotype modifications on IL2RG was conducted using
Platinum Taq DNA Polymerase (Thermo Fisher Scien-
tific). PCR conditions were as follows, initial denature at
95 °C for 2 min, denature at 95 °C for 30 s, annealing at
55 °C for 30 s and extension at 72 °C for 30 s for 34 cy-
cles. The amplicons were sent to VBI (Biocomplexity
institute of Virginia) for sequencing (primer information
is in Additional file 1: Table S3). Using extended
primers, fetus #3 and #6 were conducted PCR again.
PCR conditions were as follows, initial denature at 95 °C
for 2 min, denature at 95 °C for 30 s, annealing at 55 °C
for 30 s and extension at 72 °C for 2 min for 34 cycles.
The fetuses were cut into small pieces and digested with
0.25 % trypsin–0.02 % EDTA for 30 min at 37 °C.
Following trypsinization, the cells were washed by cen-
trifugation and subsequently seeded on to culture dishes
and cultured in DMEM (Gibco BRL, Grand Island, NY,
USA) supplemented with 15 % fetal bovine serum
(HyClone #AVM90621, USA) and 1 % penicillin/strepto-
mycin under 5 % CO2 at 37.5 °C. After 3 days of culture
the tissue explants were removed by rinsing the flask
with Dulbecco’s phosphate buffered saline (DPBS; Gibco
BRL) and the remaining attached fibroblast cells were
cultured until confluence.
Detection of mutations on IL2RG generated by the
CRISPR/Cas9 system
Genomic DNA from each cell colony was extracted
using a DNA extraction kit (iNtRon Biotechnology,
Seongnam-si, Korea), following the manufacturer’s in-
structions. To confirm genetic modifications on IL2RG
from the cell colonies, PCR was conducted using 2×
Taq. Premix (PCR Biosystems, London, UK). PCR was
performed at 40 cycles with porcine IL2RG specific
primers using the following conditions; one cycle of ini-
tial-denaturation at 95 °C for 5 min followed by 40 cycles of
denaturation at 95 °C for 60 s, annealing at 52 °C for 30 s,
and elongation at 72 °C for 30 s, and a cycle of post-
elongation at 72 °C for 10 min. Additional file 1: Table S3
shows sequences of primers used for genotyping. Mutations
on IL2RG gene were assessed by digesting PCR amplicons
with the T7 endonuclease I (T7E1) enzyme as previously
described [12]. The PCR products from the DNA isolated
from colonies were denatured at 95 °C for 5 min and re-an-
nealed at room temperature for 10 min, then digested by
T7E1 (ToolGen labs, Seoul, Korea) at 37 °C for 0.5 h.
Digestion of the PCR products was expected if the colony
contained mutated IL2RG. PCR products with potential
modification of IL2RG were confirmed by sequencing.
Somatic cell nuclear transfer and embryo transfer
SCNT was performed as described in previous studies
[12, 42]. Pig ovaries were collected from a local abattoir
and transported to the laboratory in 0.9 % (w/v) NaCl
solution at 25–30 °C. Oocytes were aspirated from antral
follicles (3–6 mm in diameter) and cultured in matur-
ation medium at 39 °C with 5 % CO2 at 100 % humidity.
After 44 h of maturation, denuded oocytes which ex-
truded the first polar body were used for SCNT. Mature
MII oocytes were enucleated by aspirating the first polar
body and adjacent cytoplasm with a thin glass pipette
(20 um in diameter) in manipulation medium supple-
mented with cytochalasin B (5 mg/ml stock, 1.5 ul per
10 ml manipulation medium). Then a single donor cell
was injected into the perivitelline space of enucleated
oocytes. Oocyte cytoplasm-cell complexes were then
fused and activated by electric pulse (ECM 2001; BTX
Inc., San Diego, CA, USA, two DC pulses of 1.1 kV/cm
for 60 μsec). Reconstructed embryos were cultured in
PZM3 in 5 % CO2 at 39 °C with 0.5 uM Scriptaid, a his-
tone deacetylase inhibitor, for 14–16 h. Embryos with an
intact plasma membrane were surgically transferred into
the oviduct of a surrogate (average 230 embryos) at the
two day after observed estrus. Successful pregnancy was
assessed by an ultrasound at day 28 days post embryo
transfer. The gestation was monitored every 2 weeks.
After approximately 114 days, cloned piglets were deliv-
ered by c-section from recipients. On the day of birth, a
tale biopsy was performed on each piglet for genomic
DNA extraction and genotyping.
Flow Cytometric Analysis (FACS)
Peripheral blood mononuclear cells (PBMCs) and
splenocytes were isolated from whole blood and spleen
from IL2RG knockout pigs and age-matched control
pigs. To identify CD3+, CD4+, and CD8+ T cells and
CD21+ B cells, mouse anti-pig CD3e (Southern Biotech,
AL, USA), CD4a, CD8a, and mouse anti-human CD21
(BD Pharmingen, CA, USA) were used in this study.
Mouse anti-pig CD16 (AbD Serotec, NC, USA) and
mouse anti-pig monocyte and granulocyte (M/G, BD
Pharmingen, CA, USA) were also used in this study for
detection of NK cell population. A total of 5 × 105
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PBMCs or splenocytes were incubated with the indicated
Abs for 40 min at 4 °C and washed twice with PBE. At
least 10,000 cells were analyzed per run. Samples were
analyzed using a FACS Calibur system with CELLQUEST
software (BD Bioseciences, CA, USA). Each experiment
was repeated at least three times.
Histological analysis
Spleens from IL2RG knockout and age-matched wild-
type pigs were first fixed in 10 % neutral buffered forma-
lin. The fixed tissues were embedded in paraffin and
sectioned for H&E staining and immunohistochemistry
(IHC). In IHC, rabbit anti-pig CD3 antibody (abcam,
MA, USA) as T lymphocytes marker and mouse anti-pig
CD79a antibody (abcam, MA, USA) as B lymphocytes
marker were used for analysis of distribution of T and B
lymphocytes.
Results
Design of CRISPR/Cas9 vector and isolation of IL2RG
knockout cells
Porcine IL2RG is located on the X chromosome and
consists of 8 exons [7]. In this study, we constructed
CRISPR/Cas9 systems that can target exon 1 of porcine
IL2RG, which contains the first translation initiation site
(Fig. 1a). Schematic construction of the CRISPR/Cas9
system used in this study is shown in Fig. 1b. When
10 ng/μl sgRNA and 20 ng/μl Cas9 mRNA were intro-
duced into developing embryos and subsequent embryos
were genotyped, all embryos carried mutations in IL2RG;
no wild-type sequence was found from the in vitro
analysis (Table 1). Transferring IVF embryos injected
with the RNA form of CRISPR/Cas9 system resulted in
one pregnancy (Table 2) and six fetuses were collected
from the surrogate to establish IL2RG knockout cell
lines. The fetuses and cell lines were screened by the
T7E1 assay and PCR DNA sequencing to detect poten-
tial mutation generated by the CRISPR/Cas9 system.
Mutations in the IL2RG were found in fetus #1, #2, #4,
and #5. No PCR amplicon was acquired from fetuses #3
and #6 even by using extended primers, suggesting that
two fetus carried large deletions (>2 kb) by CRISPR/Cas9
system (Fig. 1c). The efficacy of introducing mutations in
the IL2RG was 100 % (Additional file 1: Table S4).
Genotyping fetus #4 indicated that the cells carried biallelic
mutation (2 bp or 93 bp deletion) in IL2RG. The cells were
used to generate IL2RG knockout female pigs (Fig. 1d). The
results demonstrate that the CRISPR/Cas9-mediated target-
ing is effective in generating mutations in the genome of
porcine developing embryos.
Production of IL2RG knockout pigs
IL2RG knockout pigs were produced by SCNT from the
targeted fibroblast cells. Reconstructed embryos were
transferred to three surrogates, and one of the surro-
gates had a full-term pregnancy (Table 2). Three female
cloned pigs were obtained from the recipient via
cesarean section (Fig. 2a). PCR genotyping, T7E1 assay
and DNA sequence analyses of the 3 cloned pigs showed
that all 3 pigs had the same mutation as the nuclear
donor cells (2 bp and 93 bp deletion, Fig. 2b). Three
survivors died from pneumonia and severe arthritis or
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Fig. 1 Use of CRISPR/Cas9 system to disrupt IL2RG in pigs. a Design of CRISPRs to target IL2RG. Sequences in green and blue indicate target
sequences and letters in red reflect PAM (NGG) sequences. Red arrows indicate the location of primers used to genotype embryos and piglets.
Black arrows indicate the location of extended primers. b Schematic strategy used to produce IL2RG deficient pigs. IL2RG knockout cells lines
were established from fetuses derived from CRISPR/Cas9 injected embryos. SCNT was performed to generate IL2RG knockout female pigs. c PCR
amplification to genotype IL2RG knockout fetuses. Various mutations were detected from fetus 1, 2, 4, and 5. d Genotype of IL2RG knockout cell
line used for SCNT 4. Bold letters indicate insertion or change in nucleotides, and ‘-’ indicates deletion of nucleotide
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unknown cause(s) (all were euthanized) between postnatal
day 1 (P1) and P12.
Phenotypic characterization of IL2RG knockout pigs
All piglets were raised under standard housing condi-
tions and all the IL2RG knockout piglets presented
health issues. Necropsy results from the knockout pigs
and age-matched wild-type demonstrated that the IL2RG
piglets were immunodeficient. The biallelic IL2RG
knockout piglets lacked thymus compared with age-
matched wild-type pigs (Fig. 2c). Although there was no
obvious difference in size, the spleens of biallelic IL2RG
knockout pigs were much thinner and more loosely
packed than those of age-matched wild-type pigs. The
spleens were fixed and embedded for H&E staining to
further analyze its inner structure and cell composition.
The spleens of biallelic IL2RG knockout pigs were hypo-
plastic in the central artery of periarterial lymphatic
sheath, and lacked white pulp (Fig. 2c). In IHC, CD3
positive T lymphocytes and CD79α positive B lympho-
cytes were absent or less existed in collected spleen
samples of all piglets, showing that the number of
lymphocytes was remarkably reduced in the biallelic
IL2RG knockout pigs compared with the wild-type con-
trols (Fig. 2c). However, one littermate having longest
survival period (d12) have some CD79α positive B
lymphocytes alike other littermate.
To detect the status of B, T lymphocytes and NK cells
in the biallelic knockout pigs, cells were collected from
spleen and whole blood. Then the cells were used to
perform FACS assay. Staining the splenocytes and
PBMC with CD3, CD4 and CD8 Abs demonstrated that
the biallelic knockout pigs had almost no CD4/CD8
single- and double-positive (+) cells compared with the
wild-type controls. The ratio of CD3+CD4+ and CD3
+CD8+ cells also decreased drastically in the knockout
pigs, whereas ratios of about 20 % (respectively) were
observed in the wild-type counterparts, indicating the
lack of T lymphocytes in PB and spleen. The average
number of B cell (CD21+) was significantly lower in the
knockout piglets compared with the wild-type. However,
B cells were detected from a cloned piglet with the lon-
gest survival period (P12); the level was 36.7 %, similar
to 36.5 % in spleen of wildtype, compared with other lit-
termate lacking B cells (4.86 %). This result is consistent
with IHC result. The number of NK cells (M/G−, CD16+)
was notably lower in IL2RG knockout pigs than wild-type
pigs (Fig. 3).
Discussion
IL2RG is responsible for growth and maturation of im-
mune cells such as T cells and NK cells because it is a
common component of many interleukin receptors. In
this study, we generated IL2RG knockout pigs by using
CRISPR/Cas9 system-mediated gene targeting strategy.
These knockout pigs presented SCID phenotype as
expected. Because of the SCID phenotype, the IL2RG
knockout pigs can be used as research model for in vivo
stem cell repopulation. IL2RG homozygous knockout
mouse model has been an excellent recipient model for
engraftment of human cells [10]. For instance, IL2RG
null mice have significantly improved engraftment
results compared with other immunocompromised
SCID model when human cord blood engraftment was
attempted [21]. The IL2RG knockout pig model can be a
more useful animal model considering the discrepancy
between immune cell function and the immune system
of humans and rodents.
In this study, we injected CRISPR/Cas9 systems dir-
ectly into developing embryos to target IL2RG. The effi-
cacy of this approach was effective as all resulting
embryos and fetuses carried mutation in IL2RG. Because
the approach may lead to animals with different
Table 1 Efficacy of CRISPR/Cas9 system to induce targeted disruption of IL2RG during embryogenesis in vitro. CRISPR/Cas9 system
at the concentration of 10 ng/ul each sgRNAs and 20 ng/ul Cas9 mRNA was introduced into pig zygotes. Genotyping of subsequent






















10/20 70 25.71 %
(18/70)
4 0 2 2 0 0
Table 2 Embryo transfer results. A total of five embryo transfers
were performed in this study. Transferring CRISPR/Cas9 injected
IVF embryos was to generate IL2RG knockout fetuses. IL2RG















73-10 128 124 IVF No –
Y463 117 93 IVF Yes 6
104–154 262 262 SCNT Yes 3
28–35 283 283 SCNT No –
27–78 352 352 SCNT No –
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genotypes and mosaicism [20], fetal fibroblast cells from
each fetus were genotyped and used for SCNT to gener-
ate IL2RG knockout pigs. With this approach, exact
genotype of nuclear donor cells can be identified prior
to the production of cloned animals; this can assure the
production of animals only carrying desired modifica-
tion. Using this approach, IL2RG knockout pigs were
produced at a higher rate compared to traditional gene
targeting approach which utilizes endogenous homolo-
gous recombination mechanism in somatic cells.
Because IL2RG is located on the X chromosome and
generating animals carrying multi-allelic modifications is
challenging, previous reports of IL2RG knockout pigs
were all in male [38]. However, using the CRISPR/Cas9
system, we could generate female IL2RG deficient pigs.
A recent study demonstrates generation of RAG2/IL2RG
knockout females [16], however, to our best knowledge,
this is the first report of female IL2RG deficient pigs.
Opportunistic infections in SCID animals after birth
are unavoidable under conventional housing conditions.
We therefore recovered full-term IL2RG knockout pig-
lets recovered via cesarean section (114 d of gestation)
to avoid any risk of infection during parturition. How-
ever, the IL2RG knockout pigs could not thrive and only
lasted a short period (<12 days) because of unavoidable
opportunistic infection due to their SCID condition
under conventional housing conditions, not pathogen-
free facilities..At postmortem examination, these animals
have showed a pleural fluid inside the thoracic cavity,














Fig. 2 Generation of IL2RG knockout pigs. a An image of IL2RG knockout pigs produced in this study (b) Genotypes of IL2RG knockout female
piglets. The dots indicate the deletion mutation in the sequence of IL2RG knockout pigs. c Immunodeficiency presented in IL2RG knockout pigs.
The thymic phenotype in IL2RG knockout pigs shows absence of thymus compared to normal thymuses in wild-type pigs. Dotted yellow circle
indicates the location of thymus. The histological analysis of the spleens of wild-type and IL2RG knockout pigs indicate that IL2RG knockout pigs
lack T and B cells (Original magnification 200×)
Kang et al. Reproductive Biology and Endocrinology  (2016) 14:74 Page 6 of 9
early death of the IL2RG knockout pigs is probably be-
cause of deficient in functional immune system. Gener-
ally, long-term maintenance of severely immunodeficient
animals would require housing under pathogen-free
conditions. Therefore, management of additional IL2RG
animals should be conducted at facilities severely con-
trolled against exogenous pathogens.
A marked decrease in the number of T and B cells has
been reported in XSCID mice [3, 5] and rat [20]. In
human XSCID patients, although the number of T and
NK cells is significantly decreased, the number of B cells
remains normal or is occasionally increased [2, 33].
Similarly, IL2RG knockout pigs produced in previous
studies lacked T and NK cells but showed normal B cell
populations, and identical phenotypic characteristics
were shown identically in human XSCID [34, 38]. How-
ever, some IL2RG knockout pigs obtained in this study
showed an absent or lower B cell population; the level of
T and NK cells was lower as expected, although one lit-
termate have similar B cell population with control. This
discrepancy could come from gender biased effect. As
mentioned above, all the previous reports of IL2RG
modifications in pigs were in males. And most of human
XSCID cases are also in male. Interestingly, some re-
ports in mice indicate that there is difference in immune
responses of SCID mice based on the gender. Female
SCID mice were more effective in supporting engraft-
ment of foreign cells compared to their male counter-
part [21, 25]. Specifically, repopulation experiment of
human hematopoietic stem cells using female immuno-
deficient mice (NOD/SCID/IL2RG -null) showed that
female recipients displayed higher engraftment efficiency
compared to male [25]. In this study, the difference in B


























Fig. 3 Flowcytometric analysis of IL2RG knockout pigs. a Flowcytometric analysis of T, B and NK cells in the peripheral blood mononuclear cells and
splenocytes of wild-type piglets. b Flowcytometric analysis of T, B and NK cells in the peripheral blood mononuclear cells and splenocytes of IL2RG
knockout pigs. In figure (A) and (B), the dot plots show CD3+, CD4+ and CD8+ cells for the demarcation of T cell subpopulations and CD3−, CD21+ cells
for the differentiation of B cell, M/G− cells and CD16+ cells for the differentiation of NK cell subpopulations. c The proportion ratio of T, B and NK cells
in PBMC of wild-type and IL2RG knockout pigs
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genetic modification was unexpected. We speculate that
this discrepancy is probably due to unexpected changes in
epigenetic make-up of the X chromosome. Mammalian
IL2RG orthologs are typically located on the X chromo-
some and in female one of the X chromosomes is inacti-
vated during early development. Clones are known to
have abnormally skewed pattern of X inactivation [30],
and this could be a reason behind the differences in the
level of B cells among IL2RG knockout pigs produced in
this study. Our further studies will focus on the functional
differences in IL2RG between genders in pigs. Also, modi-
fication of epigenetic pattern in same littermate produced
in this study will be additionally studied.
Conclusions
Genome editing by CRISPR/Cas9-mediated technology
represents a practical strategy for the production of genetic-
ally engineered pigs. Using this technology enabled inacti-
vation of IL2RG gene in pigs. In this study, we generated
IL2RG knockout female pigs showing phenotypic
characterization of SCID. This IL2RG knockout female pig
model will greatly contribute not only to cancer and stem
cell research but also to preclinical evaluations of the trans-
plantation of pluripotent stem cells, such as iPS cells.
Additional file
Additional file 1: Table S1. Oligos used to introduce sgRNA into px330.
Each pair of forward and reverse primers were annealing and ligated into
the PX330 vector. Table S2. Primers used to generate template DNA for in
vitro transcription to produce sgRNA and mRNA form of Cas9. Table S3.
Primers used to genotype IL2RG mutations introduced by CRISPR/Cas9
system. The extend primers were used to genotype IL2RG from fetus 3 and
6. Table S4. The mutation of fetus. Two fetus contained hemizygous
mutation in IL2RG, other two fetus had biallelic mutation, and 2 fetus had
presumable large deletion (>1.9kb). (DOCX 22 kb)
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